Tyra Biosciences (TYRA) Shares Outstanding (Diluted Average) (2021 - 2026)

Tyra Biosciences has reported Shares Outstanding (Diluted Average) for 6 years, with the latest figure at $61.7 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) rose 4.06% year-over-year to $61.7 million; the trailing twelve-month figure through Mar 2026 stood at $61.7 million (up 4.06% YoY), and the FY2025 full-year result was $59.6 million, up 4.17% from the prior year.
• Shares Outstanding (Diluted Average) for Q1 2026 stood at $61.7 million, up from $59.6 million in the prior quarter.
• The five-year high for Shares Outstanding (Diluted Average) was $61.7 million in Q1 2026, with the low at $41.6 million in Q1 2022.
• Historically, Shares Outstanding (Diluted Average) has averaged $50.8 million across 5 years, with a median of $52.2 million in 2024.
• Annual changes were most pronounced in 2022 — Shares Outstanding (Diluted Average) surged 1847.07% — and 2025, when it rose 1.32%.
• Tyra Biosciences' Shares Outstanding (Diluted Average) stood at $41.9 million in 2022, then advanced by 1.96% to $42.7 million in 2023, then jumped by 33.98% to $57.2 million in 2024, then rose by 4.17% to $59.6 million in 2025, then rose by 3.6% to $61.7 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $61.7 million (Q1 2026), $59.6 million (Q4 2025), and $59.7 million (Q3 2025), per Business Quant data.